13 hasil untuk "Ajantha Solomon"
Menampilkan 1–13 · 1,64 detik · RSS
-
Artikel Jurnal Teks lengkap
No Difference in the Rate of Change in Telomere Length or Telomerase Activity in HIV-Infected Patients after Three Years of Darunavir/Ritonavir with and without Nucleoside Analogues in the MONET Trial
Objective: To determine whether nucleos(t)ide reverse transcriptase inhibitors (NRTI) contribute to an accelerated loss in telomere length (TL) in HIV-infected patients on antiretroviral therapy (ART). Design: Substudy of randomised controlled trial. Methods: Patients with HIV RNA
Juga tersedia di: DOAJ
-
Artikel Jurnal Teks lengkap
Understanding Factors That Modulate the Establishment of HIV Latency in Resting CD4+ T-Cells In Vitro
Developing robust in vitro models of HIV latency is needed to better understand how latency is established, maintained and reversed. In this study, we examined the effects of donor variability, HIV titre and co-receptor usage on establishing HIV latency in vitro using two models of HIV latency…
Juga tersedia di: DOAJ
-
Artikel Jurnal Teks lengkap
The effect of combining HIV latency reversal with inhibition of phosphoinositide-3 kinases or B-cell lymphoma-2 on the HIV reservoir
The persistence of latently infected CD4 + T-cells in people with HIV (PWH) on suppressive antiretroviral therapy (ART) is the major barrier to an HIV cure. We investigated the impact of two classes of pro-apoptotic drugs, phosphoinositide-3 kinases (PI3K) inhibitors or the B cell lymphoma 2…
Juga tersedia di: DOAJ
-
Artikel Jurnal
Pomalidomide enhances CD8+ T and NK cell mediated killing of HIV-infected cellsResearch in context
Summary: Background: Overcoming persisting immune dysfunction in people living with HIV (PLHIV) on suppressive antiretroviral therapy (ART) is a key challenge to curing HIV. Agents that reverse immune dysfunction may enhance viral immunity to support the immunological control and clearance of…
-
Artikel Jurnal Teks lengkap
Diverse effects of interferon alpha on the establishment and reversal of HIV latency
HIV latency is the major barrier to a cure for people living with HIV (PLWH) on antiretroviral therapy (ART) because the virus persists in long-lived non-proliferating and proliferating latently infected CD4+ T cells. Latently infected CD4+ T cells do not express viral proteins and are therefore…
Juga tersedia di: DOAJ
-
Artikel Jurnal
Broad activation of latent HIV-1 in vivo
Treatment of HIV-1 infected patients with latency-reversing agents (LRA) induces transcription of proviruses in CD4 T cells. Using single-genome sequencing, the authors show that the LRA-induced CD4 T cell-associated HIV RNA is genetically diverse and contains a high proportion of defective RNA.
-
Artikel Jurnal
In vivo effect of anti-PD-1 on HIV-specific CD8+T-cells in men with HIV
Abstract One approach to achieve a cure for HIV infection or allow for people with HIV to safely stop antiretroviral therapy is to enhance HIV-specific immune function by reversing immune exhaustion. Immune checkpoint blockade with anti-PD1 can enhance virus-specific T-cell function ex vivo and in…
-
Artikel Jurnal Teks lengkap
Activation of HIV Transcription with Short-Course Vorinostat in HIV-Infected Patients on Suppressive Antiretroviral Therapy
: Human immunodeficiency virus (HIV) persistence in latently infected resting memory CD4+ T-cells is the major barrier to HIV cure. Cellular histone deacetylases (HDACs) are important in maintaining HIV latency and histone deacetylase inhibitors (HDACi) may reverse latency by activating HIV…
Juga tersedia di: DOAJ